中国医师协会脑胶质瘤专委会老年胶质瘤学组. 中国老年胶质瘤患者术前评估专家共识(2019)[J]. 协和医学杂志, 2019, 10(4): 326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004
引用本文: 中国医师协会脑胶质瘤专委会老年胶质瘤学组. 中国老年胶质瘤患者术前评估专家共识(2019)[J]. 协和医学杂志, 2019, 10(4): 326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004
Glioma Committee of the Gerontology Section of Chinese Medical Doctor Association. Expert Consensus on the Preoperative Geriatric Assessments of Elderly Patients with Glioma (2019)[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004
Citation: Glioma Committee of the Gerontology Section of Chinese Medical Doctor Association. Expert Consensus on the Preoperative Geriatric Assessments of Elderly Patients with Glioma (2019)[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004

中国老年胶质瘤患者术前评估专家共识(2019)

Expert Consensus on the Preoperative Geriatric Assessments of Elderly Patients with Glioma (2019)

  • 摘要: 胶质瘤是成年人中最常见的原发性脑肿瘤,其中以胶质母细胞瘤(glioblastoma,GBM)恶性程度最高。目前针对胶质瘤患者的治疗方式主要包括手术切除、放疗和化疗,而GBM的治疗策略,特别是老年GBM患者的治疗策略,尤其是手术方式,常因其自身特点而产生差异。术前系统而全面的评估有助于总结老年GBM的临床特点及相应诊疗方案,为临床医生提供更全面的患者信息,以更加准确判断老年患者对手术的耐受程度以及预测患者预后。本专家共识在对最新研究证据进行系统回顾的基础上,将目前已广泛应用的胶质瘤术前评估项目及评估工具进行总结,初步建立中国老年胶质瘤患者术前评估体系。

     

    Abstract: Glioma is the most common primary brain tumor in adults, among which glioblastoma (GBM) is the most malignant. At present, the therapeutic regimen for patients with glioma mainly includes surgery, radiotherapy, and chemotherapy. However, the treatment strategy for elderly patients with GBM often varies because of their characteristics. A systematic and comprehensive assessment before the operation will be helpful to summarize clinical characteristics of elderly patients with GBM, and can provide clinicians with more comprehensive clinical information in order to evaluate the patient's tolerance to surgery and predict the prognosis. Based on a systematic review of the latest research, this expert consensus summarizes the most widely used and studied tools of preoperative assessment of glioma, and initially establishes a preoperative evaluation system for elderly patients with glioma in China.

     

/

返回文章
返回